Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) has repurchased a cumulative 5.04% of its shares, spending 94.27 million yuan.

18/09/2024

GMT Eight

Announcement from Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ): As of September 18, 2024, the company has repurchased a total of 4.074 million shares, accounting for 5.0418% of the current total share capital. The highest transaction price was 26.22 yuan per share, the lowest transaction price was 20.65 yuan per share, and the total transaction amount was 94.2704 million yuan (excluding transaction fees).

Zhejiang Huahai Pharmaceutical (600521.SH) obtains registration certificate for orally disintegrating tablets of enalapril maleate and alprazolam oral solution.

Contact: contact@gmteight.com

Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) has repurchased a cumulative 5.04% of its shares, spending 94.27 million yuan.

RECOMMEND

A-shares market review | Three major indexes rallied in the final moments, with mysterious funds making another move! Several ETFs surged in trading volume.

HK Stock Market Move | CMOC Group Limited (03993) rises nearly 5% in the afternoon, as demand is concentrated, stimulating the price of molybdenum. Overseas interest rate cuts are expected to boost base metals.

Under the imbalance of supply and demand, a large number of new factories have started production, signalling the end of the global oil refining industry's "super cycle."